|
Decompression Intervention of Variceal Rebleeding Trial (DIVERT) Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Decompression Intervention of Variceal Rebleeding Trial (DIVERT) conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Decompression Intervention of Variceal Rebleeding Trial (DIVERT) Clinical research trials and Decompression Intervention of Variceal Rebleeding Trial (DIVERT) healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Decompression Intervention of Variceal Rebleeding Trial (DIVERT). Decompression Intervention of Variceal Rebleeding Trial (DIVERT) Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Decompression Intervention of Variceal Rebleeding Trial (DIVERT) clinical trial. Human subjects often obtain the finest healthcare possible for their Decompression Intervention of Variceal Rebleeding Trial (DIVERT) condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Decompression Intervention of Variceal Rebleeding Trial (DIVERT)  Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
For Condition: Esophageal and Gastric Varices,Liver Cirrhosis
Status: Completed
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: The Decompression Intervention of Variceal Rebleeding Trial (DIVERT) is a multi-center prospective randomized clinical trial comparing the radiologic procedure of transjugular intrahepatic portal-systemic shunt (TIPS) with the surgical procedure of distal splenorenal shunt (DSRS) for variceal bleeding in patients with Child's Class A and B cirrhosis. This is recognized nationally and internationally as the study that will answer the question as to which of these is the best treatment for decompression of varices in patients who have failed endoscopic and pharmacologic therapy.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Variceal bleeding secondary to cirrhosis and portal hypertension - Child's Class A or B cirrhosis of any etiology - Patients who have failed endoscopic therapy (sclerotherapy or banding) of varices; or patients who are not candidates for endoscopic therapy Exclusion Criteria: - Prior shunt procedure - Portal vein thrombosis - Polycystic liver disease - Intractable ascites - Prior organ transplant - Any medical intractable disease
Total Enrollment: 140
Location and Contact Information:
Overall Study Official:
J.Henderson, Principal Investigator, Cleveland Clinic Foundation Hospital
Emory University
Atlanta, Georgia, 30322
United States
University of Wisconsin
Madison, Wisconsin, 53792
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213
United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
United States
University of Miami School of Medicine
Miami, Florida, 31336
United States
Additional Information:
Study ID Numbers: DIVERT; DK50680-02
Study Start Date: December 1996
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006161
Other Liver Cirrhosis Studies:
1. Prevention of Esophageal Varices by Beta-Adrenergic Blockers
2. A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients with Cirrhosis
3. Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
Related Studies:
Other Liver Cirrhosis Clinical Trials
Other Pennsylvania Clinical Trials
Other Pittsburgh Clinical Trials
Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
|
|
|
|
|
|
|
|
